Research programs

Our research aims to offer new treatment methods that will make a real difference to patients worldwide
AOCMF Strategic Research Programs

Strategic Research Areas


  • Bone defects/healing

  • Fracture treatment

  • Clinical planning

  • Clinical outcomes

AOCMF Research Strategy

AOCMF Research Strategy

Research Focus: ARONJ


ARONJ is the AOCMF’s Clinical Priority Program (CPP) on “Anti-osteoclastic drugs and their impact on maxillofacial and orthopedic bone biology, disease, diagnostics, prevention, and treatment modalities.”

The program includes:

  • Guide to Research book
  • Open calls for proposals
  • Projects with the AO Research Institute Davos



Overview of on-going
ARONJ projects: 

  • Prevention and treatment of ARONJ using blood-derived endothelial progenitor cells
  • Large animal model for antiresorptive drug-induced osteonecrosis of the jaw
  • Prevention of bisphosphonate-related osteonecrosis of the jaws using a novel tissue engineering strategy
  • Bisphosphonate-related osteonecrosis of the jaw—the role of soft tissue healing

Browse past projects

Current ARONJ highlights